SE0001499L - Medel för att förbättra cerebral frisättning av acetylkolin - Google Patents

Medel för att förbättra cerebral frisättning av acetylkolin

Info

Publication number
SE0001499L
SE0001499L SE0001499A SE0001499A SE0001499L SE 0001499 L SE0001499 L SE 0001499L SE 0001499 A SE0001499 A SE 0001499A SE 0001499 A SE0001499 A SE 0001499A SE 0001499 L SE0001499 L SE 0001499L
Authority
SE
Sweden
Prior art keywords
anisoyl
release
gaba
acetylcholine
anisic acid
Prior art date
Application number
SE0001499A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE0001499D0 (sv
Inventor
Kazuo Nakamura
Masatoshi Shirane
Yushiro Tanaka
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE0001499D0 publication Critical patent/SE0001499D0/xx
Publication of SE0001499L publication Critical patent/SE0001499L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0001499A 1999-04-27 2000-04-26 Medel för att förbättra cerebral frisättning av acetylkolin SE0001499L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99108223 1999-04-27

Publications (2)

Publication Number Publication Date
SE0001499D0 SE0001499D0 (sv) 2000-04-26
SE0001499L true SE0001499L (sv) 2000-10-28

Family

ID=8238054

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001499A SE0001499L (sv) 1999-04-27 2000-04-26 Medel för att förbättra cerebral frisättning av acetylkolin

Country Status (24)

Country Link
US (1) US20030073744A1 (ja)
JP (1) JP2000309529A (ja)
KR (1) KR100372906B1 (ja)
CN (1) CN1277019A (ja)
AR (1) AR023763A1 (ja)
AT (1) AT408836B (ja)
AU (1) AU3011300A (ja)
BE (1) BE1013314A3 (ja)
BR (1) BR0002381A (ja)
CA (1) CA2307022A1 (ja)
DE (1) DE10020237A1 (ja)
DK (1) DK200000687A (ja)
ES (1) ES2176078A1 (ja)
FI (1) FI20000977L (ja)
FR (1) FR2792833B1 (ja)
GB (1) GB2351662A (ja)
GR (1) GR1003591B (ja)
IE (1) IE20000308A1 (ja)
IT (1) IT1318490B1 (ja)
NL (1) NL1015043C2 (ja)
PT (1) PT102456B (ja)
SE (1) SE0001499L (ja)
TR (1) TR200001133A2 (ja)
ZA (1) ZA200002041B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5273731B2 (ja) * 2009-08-11 2013-08-28 独立行政法人産業技術総合研究所 生体リズムの制御剤
KR20210090688A (ko) * 2018-11-13 2021-07-20 시엔펑 펑 아미노산의 아실화 유도체가 동물 사료 첨가제의 제조에 있어서의 응용

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
JPH1081607A (ja) * 1996-09-06 1998-03-31 Kamiyama:Kk 抗菌剤
JPH1081626A (ja) * 1996-09-06 1998-03-31 Kamiyama:Kk チロシナーゼ活性阻害剤

Also Published As

Publication number Publication date
ATA7162000A (de) 2001-08-15
ITMI20000914A1 (it) 2001-10-21
FI20000977A0 (fi) 2000-04-26
ITMI20000914A0 (it) 2000-04-21
JP2000309529A (ja) 2000-11-07
KR100372906B1 (ko) 2003-02-17
US20030073744A1 (en) 2003-04-17
BR0002381A (pt) 2000-11-07
AU3011300A (en) 2000-11-02
KR20010029658A (ko) 2001-04-06
GR1003591B (el) 2001-05-22
ES2176078A1 (es) 2002-11-16
BE1013314A3 (fr) 2001-11-06
TR200001133A2 (tr) 2000-11-21
GB2351662A (en) 2001-01-10
ZA200002041B (en) 2000-10-27
FR2792833A1 (fr) 2000-11-03
DK200000687A (da) 2000-10-28
NL1015043C2 (nl) 2001-03-30
CA2307022A1 (en) 2000-10-27
IE20000308A1 (en) 2000-11-29
DE10020237A1 (de) 2001-02-08
NL1015043A1 (nl) 2000-10-30
FI20000977A7 (fi) 2000-10-27
GB0010049D0 (en) 2000-06-14
PT102456B (pt) 2003-04-30
GR20000100145A (el) 2000-12-29
AT408836B (de) 2002-03-25
IT1318490B1 (it) 2003-08-25
AR023763A1 (es) 2002-09-04
FI20000977L (fi) 2000-10-27
PT102456A (pt) 2000-11-30
FR2792833B1 (fr) 2002-09-06
SE0001499D0 (sv) 2000-04-26
CN1277019A (zh) 2000-12-20

Similar Documents

Publication Publication Date Title
DE59712501D1 (de) 1-benzyl-3-(substituiertes-hetaryl)-kondensierten pyrazol-derivaten zur behandlung von erkrankungen des herz-kreislaufsystems und des zentralnervensystems
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
NO20100496L (no) Derivater av venlafaksin og anvendelse av samme
TR200201094T2 (tr) Farmasötik maddeler olarak bisiklik amino asitler
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
TW200635912A (en) Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
EA200701296A1 (ru) 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
WO2007100366A3 (en) Quinolone m1 receptor positive allosteric modulators
PE20090363A1 (es) Moduladores de la gamma secretasa
DE69928563D1 (de) Verabreichung von neurotropischen wirkstoffen in das zentrale nervensystem
DE60135647D1 (de) Zusammensetzungen zur normalisierung des zirkadianen rythmus
EE200100491A (et) Tetrahüdropüraani derivaadid, nende saamine ja kasutamine ravimainetena ning neid sisaldav farmatseutiline kompositsioon
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
EP1852114A4 (en) COMPOSITION WITH DIHOMO (GAMMA) LINE ACIDIC ACID (DGLA) AS AN ACTIVE INGREDIENTS
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
ATE422201T1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
MXPA05013226A (es) Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas.